PRTN3 and interstitial lung disease: We also investigated the weight of serum markers for the diagnosis of RA-ILD, in comparison with known RA-ILD risk factors including age at onset, disease duration, smoking status, gender, ACPA, CRP levels, treatment with MTX and targeted biologic therapies.